...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Why have we not heard more about CURATE-AI?

narmac, I recall Don making a statement something to the effect that if they wanted to continue using the CURATE system that Zenith would have to pay for it's use.

Obviously someone did not think it had enough value to pay for it.

Toinv

Share
New Message
Please login to post a reply